A fortnightly call where Amati Managers aim to share opinions on key events over the previous weeks. 10 – 15 minutes of concise comment at 8:45am every second Tuesday.
Recent conversations with the industry suggest that RFID and other wireless IoT technologies continue to unlock new transformative applications – from retail to healthcare to everyday consumer life. Join Amati Global Innovation fund managers Mikhail Zverev and Graeme Bencke as they discuss how they are investing to benefit from what’s coming next.
Alzheimer’s Disease is one of the most pressing unmet clinical needs and is a huge cost to healthcare systems and societies. Recent developments in Alzheimer’s diagnostics are nothing short of revolutionary and promise to unlock improved patient outcomes and valuable new markets. Join Amati managers Mikhail Zverev and Graeme Bencke as they discuss how they pursue this opportunity in the WS Amati Global Innovation Fund.
Join Mikhail Zverev and Graeme Bencke from the WS Amati Global Innovation team for a portfolio update. Discover how their disciplined, research-driven approach has enabled them to uncover innovation opportunities beyond the ubiquitous mega-cap tech stocks.
In this short update, Mikhail and Graeme will:
• Explain the principles behind our investment process and why we focus on real businesses, not science projects;
• Discuss key innovation frontiers in the portfolio that we believe remain significantly underappreciated by the market;
• Highlight how today’s shifting geopolitical and trade landscape opens new doors for active investors.
* Registration is required to view this article
| Date | Description. |
| 24/11/2025 | Gregor Patterson highlights some stock picks for the WS Amati UK Listed Smaller Companies Fund to Cherry Reynard from Interactive Investor. |
| 18/11/2025 | Graeme Bencke discusses his views on European defence stocks with Sabrina Nelson Garcinuño and Lisa Pham in Bloomberg’s* article “European Defense Stocks Hit Lowest Since April as Rally Ebbs”. |
Amati Global Investors Limited
This website is not intended to provide investment, tax or legal advice and none of its content should be construed as a recommendation to buy, sell, or hold, any security, investment product or service. You are solely responsible for determining whether any investment is appropriate for you, based on your investment objectives, financial circumstances and risk tolerance. If you are unsure about the meaning of any information provided, or if you are uncertain as to how to proceed, please consult an independent financial adviser. If you do not have a financial adviser, please contact, where information on finding one can be obtained.
Any research or analysis contained in this website has been prepared or obtained by Amati for its own use. While sources of information are believed to be reliable, no guarantee, warranty or representation is given as to their accuracy or completeness. Investment markets and conditions can change rapidly and as such any views expressed should not be taken as statements of fact nor should reliance be placed on these views when making investment decisions.
By checking the box and proceeding to the website you have confirmed that you have read and understood the information set out below and that you fully understand the risks involved in an investment of this nature.
WS Amati UK Listed Smaller Companies Fund
WS Amati Strategic Metals Fund
WS Amati Global Innovation Fund
Issued by: Amati Global Investors Limited, 8 Coates Crescent, Edinburgh EH3 7AL. Registered in Scotland (company no. SC199908). FCA reference number: 198024
Amati Global Investors is authorised and regulated by the Financial Conduct Authority.
8 Coates Crescent
Edinburgh
EH3 7AL



